Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $4.66 Analyst target: $5.41 Upside: 16.09%
CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany.
See the full interactive analysis & chart →Informational only — not investment advice.